Although currently no drugs that specifically target mitochondrial biogenesis in HF are available, acceleration of this process through adenosine monophosphate–activated kinase (AMPK), endothelial nitric oxide synthase (eNOS), and other pathways may represent a promising therapeutic approach
1More
1More
Low vitamin C levels may raise heart failure patients' risk / American Heart Association - 0 views
1More
Cardiac Surgery India Provides Expertise in All Aspects of Cardiac Care - 0 views
1More